We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

563 hedge funds and large institutions have $12.8B invested in Charles River Laboratories in 2026 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 194 increasing their positions, 199 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more call options, than puts

Call options by funds: $59M | Put options by funds: $31.7M

30% more capital invested

Capital invested by funds: $9.86B → $12.8B (+$2.98B)

24% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 62

1.65% more ownership

Funds ownership: 116.06% → 117.71% (+1.7%)

1% more funds holding

Funds holding: 559 → 563 (+4)

3% less repeat investments, than reductions

Existing positions increased: 194 | Existing positions reduced: 199

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
563
Holders Change
+4
Holders Change %
+0.72%
% of All Funds
6.8%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.06%
New
77
Increased
194
Reduced
199
Closed
62
Calls
$59M
Puts
$31.7M
Net Calls
+$27.3M
Net Calls Change
+$19.7M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$140M
2
Invesco
Invesco
Georgia
+$105M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$67.7M
4
Citigroup
Citigroup
New York
+$41.8M
5
Goldman Sachs
Goldman Sachs
New York
+$40.1M

Top Sellers

Rank Fund Capital Flow
1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
-$106M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$81.6M
3
Millennium Management
Millennium Management
New York
-$79.7M
4
Amundi
Amundi
France
-$64.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$60.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
501
Essential Partners
California
$4.76K – – –
TFA
502
Transamerica Financial Advisors
Florida
$4.54K +$534 +3 +18%
SGK
503
Steigerwald Gordon & Koch
Virginia
$4.31K – – –
KFG
504
Kingdom Financial Group
Arizona
$4.08K – – –
GBT
505
Grove Bank & Trust
Florida
$3.85K – – –
MEG
506
Millstone Evans Group
Colorado
$3.63K – – –
SC
507
SouthState Corp
Florida
$3.4K +$534 +3 +25%
MNA
508
Manning & Napier Advisors
New York
$3.16K +$2.49K +14 New
BHWM
509
Bay Harbor Wealth Management
Maryland
$2.95K +$1.25K +7 +117%
CCMI
510
Creative Capital Management Investments
California
$2.95K +$2.31K +13 New
MWA
511
Medallion Wealth Advisors
Connecticut
$2.72K – – –
SSG
512
Summit Securities Group
New York
$2.5K +$534 +3 +38%
OCWP
513
Owl Creek Wealth Partners
Colorado
$2.27K – – –
RWS
514
Retirement Wealth Solutions
Wisconsin
$2.04K +$178 +1 +13%
BH
515
Burk Holdings
Oklahoma
$2.04K – – –
FCAS
516
First Command Advisory Services
Texas
$2.04K – – –
BCWM
517
Bartlett & Co Wealth Management
Ohio
$2.04K +$712 +4 +80%
CPG
518
Cornerstone Planning Group
New Jersey
$1.97K – – –
HIA
519
HFM Investment Advisors
New Jersey
$1.81K +$890 +5 +167%
IRC
520
Investors Research Corp
Georgia
$1.81K – – –
AG
521
AmeriFlex Group
Nevada
$1.81K +$1.43K +8 New
PS
522
Planning Strategies
Pennsylvania
$1.81K +$1.43K +8 New
CT
523
Clearstead Trust
Maine
$1.59K -$1.96K -11 -61%
CT
524
Colonial Trust
South Carolina
$1.59K – – –
DPW
525
DiNuzzo Private Wealth
Pennsylvania
$1.59K – – –
19 20
21
22 23

CRL Hedge Fund Activity: Q2 2026 in Review

563 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2026, worth a combined $12.8B — up 30% from $9.86B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new CRL positions and 62 closed out — a net gain of 15 holders — while 194 added to existing stakes and 199 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $140M. The largest seller was Mackenzie Financial, cutting an estimated $106M.

  • 563 institutional investors held Charles River Laboratories (CRL) as of Q2 2026, up from 559 in Q1 2026.
  • Funds reported $12.8B of Charles River Laboratories stock for Q2 2026, up 30% quarter-over-quarter.
  • 77 funds opened new Charles River Laboratories positions in Q2 2026 and 62 closed out, a net change of +15 holders.
  • The largest Charles River Laboratories buyer in Q2 2026 was Fidelity Investments, an estimated $140M added.
  • The largest Charles River Laboratories seller in Q2 2026 was Mackenzie Financial, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2026.